ReviewFrontiers in immunology2024

Preliminary response to Tislelizumab plus chemotherapy drugs in patient with periampullary carcinoma: a report of one case and a literature review.

Chuanyun Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.